Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000735162 | SCV000863363 | uncertain significance | not provided | 2018-09-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084387 | SCV001027638 | likely benign | Wolman disease | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002458353 | SCV002616879 | likely benign | Cardiovascular phenotype | 2022-03-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000735162 | SCV004127057 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | LIPA: BP4, BP7 |
Natera, |
RCV001825487 | SCV002091466 | likely benign | Lysosomal acid lipase deficiency | 2020-04-07 | no assertion criteria provided | clinical testing |